Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells
Open Access
- 1 February 2019
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 17 (2) , 384-397
Abstract
Glioblastomas (GB) are malignant brain tumors with poor prognosis despite treatment with surgery and radio/chemotherapy. These tumors are defined by an important cellular heterogeneity and notably contain a subpopulation of GB-initiating cells (GIC), which contribute to tumor aggressiveness, resistance, and recurrence. Some integrins are specifically expressed by GICs and could be actionable targets to improve GB treatment. Here, integrin β8 (ITGB8) was identified as a potential selective target in this highly tumorigenic GIC subpopulation. Using several patient-derived primocultures, it was demonstrated that ITGB8 is overexpressed in GICs compared with their differentiated progeny. Furthermore, ITGB8 is also overexpressed in GB, and its overexpression is correlated with poor prognosis and with the expression of several other classic stem cell markers. Moreover, inhibiting ITGB8 diminished several main GIC characteristics and features, including self-renewal ability, stemness, migration potential, and tumor formation capacity. Blockade of ITGB8 significantly impaired GIC cell viability via apoptosis induction. Finally, the combination of radiotherapy and ITGB8 targeting radiosensitized GICs through postmitotic cell death. Implications: This study identifies ITGB8 as a new selective marker for GICs and as a promising therapeutic target in combination with chemo/radiotherapy for the treatment of highly aggressive brain tumors.Keywords
All Related Versions
Funding Information
- Canceropôle Grand Sud Ouest (GSO)
- Plan Cancer (ITMO cancer, INCA) - Training for Translationnal Research (ASC15031BSA)
- Plan Cancer (ITMO cancer, INSERM) - THE program (MoGlimaging)
- Groupe de Recherche Institut Claudius Regaud (GRICR) (R080)
- Plan Cancer (ITMO cancer, INCA) - Training for Translationnal Research (ASC14074BSA)
- Ministère de l'Enseignement Supérieur et de la Recherche (MESR)
- Ministère de l'Enseignement Supérieur et de la Recherche (MESR)
- Association pour la Recherche sur les Tumeurs Cérébrales (ARTC)
- Recherche Innovation Thérapeutique Cancérologie (RITC) (Stemri/RPH11003BBA)
- Institut National de la Sante et de la Recherche Medicale (INSERM)
This publication has 47 references indexed in Scilit:
- αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasionMolecular Biology of the Cell, 2013
- CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cellsLaboratory Investigation, 2012
- Glioblastoma Angiogenesis and Tumor Cell Invasiveness Are Differentially Regulated by β8 IntegrinCancer Research, 2011
- Deadly Teamwork: Neural Cancer Stem Cells and the Tumor MicroenvironmentCell Stem Cell, 2011
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human GlioblastomaCancer Cell, 2010
- Transcription of the Transforming Growth Factor β Activating Integrin β8 Subunit Is Regulated by SP3, AP-1, and the p38 PathwayJournal of Biological Chemistry, 2010
- Integrin Alpha 6 Regulates Glioblastoma Stem CellsCell Stem Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006